FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015116594> ?p ?o ?g. }

• W3015116594 endingPage "20" @default.
• W3015116594 startingPage "16" @default.
• W3015116594 abstract "If the use of highly active antiretroviral therapies (HAART) have largely improved survival, morbidity and the quality of life of the people living with HIV in Northern countries as well as Southern countries and particularly in Africa, many obstacles have slowed down their use. Thus the follow-up of the patients under HAART in certain developing countries is still limited even non-existent.The objective of this work was to bring the therapeutic outcomes obtained after a minimal six months period of follow-up among HIV+ patients admitted in external consultations or following hospitalizations.We carried out a retrospective and descriptive study concerning patients followed from January 1st, 2004 to December 31st, 2008 (5 years).Our study concerned 275 patients including 61.41% women with a sex-ratio (M/W) of 0.62. The average age of our patients was of 36.83 [rage: 18-70]. The initial average weight of our patients was 59.88 kg [range: 30-107] with the majority (66.91%) at the stage III of the WHO clinical classification. The serologic profile was dominated by HIV1 (97.09%) with a number of average CD4 of 210.99 cells/mm3 at the initiation of the ARV treatment. The evolution under treatment was marked clinically by an average ponderal gain of 7,45kg, with weight increasing from 59.88 kg to 67.33 kg between M0 and M54. Biologically, the number of average CD4 increased from 210.99 to 643 between M0 and M48 with an average gain of 432.01 cells/mm3. On the virological level, the plasmatic viral load was carried out for 64 patients out of 275. It was undetectable in 31 patients, be it 48.44%.In conclusion, the therapeutic outcomes of the patients under HAART was good at the end of this study with a satisfactory clinical issue, marked by an increase in the average weight which corroborates a good immunological and virological response.Si l'utilisation des multithérapies antirétro-virales (ARV) a grandement amélioré la survie, la morbidité et la qualité de vie des PVVIH dans les pays du Nord, dans les pays du Sud, et notamment en Afrique, de nombreux obstacles ont freiné leur utilisation. C'est ainsi que le suivi des patients sous ARV dans certains pays en voie de développement est encore timide voir inexistant.L'objectif de ce travail était de rapporter les réponses thérapeutiques obtenues après une période minimale de six mois de suivi chez des patients VIH+ admis en consultations externes ou à la suite d'hospitalisations.Il s'agissait d'une étude rétrospective de type descriptif concernant les patients suivis dans la période du 1er janvier 2004 au 31 décembre 2008, soit 5 ans.Notre étude a concernée 275 patients dont 61,41% de femmes avec un sex-ratio (H/F) de 0,62. L'âge moyen de nos patients était de 36,83 [18 70]. Le poids moyen initial de nos patients était de 59,88 kg [30 –107] avec la majorité (66,91%) au stade III de la classification clinique de l'OMS. Le profil sérologique était dominé par le VIH1 (97,09%) avec un nombre de CD4 moyen à 210,99 cellules/mm3à l'initiation du traitement ARV. L'évolution sous traitement a été marquée cliniquement par un gain pondéral moyen de 7,45kg, le poids moyen passant de 59,88 kg à 67,33 kg entre M0 et M54. Biologiquement, le nombre de CD4 moyen est passé de 210,99 à 643 entre M0 et M48 soit un gain moyen de 432,01 cellules/mm3. Sur le plan virologique, la charge virale plasmatique réalisée chez 64 patients sur 275 était indétectable chez 31 patients soit 48,44%.Globalement, la réponse thérapeutique était bonne au terme de cette étude avec une réponse clinique satisfaisante, marquée par une augmentation du poids moyen qui corrobore une bonne réponse immunologique et virologique." @default.
• W3015116594 created "2020-04-10" @default.
• W3015116594 creator A5002438457 @default.
• W3015116594 creator A5025729005 @default.
• W3015116594 creator A5032996763 @default.
• W3015116594 creator A5049901048 @default.
• W3015116594 creator A5069670787 @default.
• W3015116594 creator A5075931960 @default.
• W3015116594 creator A5076352914 @default.
• W3015116594 creator A5084619483 @default.
• W3015116594 date "2015-01-01" @default.
• W3015116594 modified "2023-09-24" @default.
• W3015116594 title "[Evaluation of antiretroviral treatment in HIV infected adult in the department of dermatology venereology of the Donka national hospital]." @default.
• W3015116594 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29927129" @default.
• W3015116594 hasPublicationYear "2015" @default.
• W3015116594 type Work @default.
• W3015116594 sameAs 3015116594 @default.
• W3015116594 citedByCount "1" @default.
• W3015116594 countsByYear W30151165942018 @default.
• W3015116594 crossrefType "journal-article" @default.
• W3015116594 hasAuthorship W3015116594A5002438457 @default.
• W3015116594 hasAuthorship W3015116594A5025729005 @default.
• W3015116594 hasAuthorship W3015116594A5032996763 @default.
• W3015116594 hasAuthorship W3015116594A5049901048 @default.
• W3015116594 hasAuthorship W3015116594A5069670787 @default.
• W3015116594 hasAuthorship W3015116594A5075931960 @default.
• W3015116594 hasAuthorship W3015116594A5076352914 @default.
• W3015116594 hasAuthorship W3015116594A5084619483 @default.
• W3015116594 hasConcept C126322002 @default.
• W3015116594 hasConcept C142462285 @default.
• W3015116594 hasConcept C159654299 @default.
• W3015116594 hasConcept C16005928 @default.
• W3015116594 hasConcept C167135981 @default.
• W3015116594 hasConcept C187212893 @default.
• W3015116594 hasConcept C195910791 @default.
• W3015116594 hasConcept C203014093 @default.
• W3015116594 hasConcept C2779437838 @default.
• W3015116594 hasConcept C2993143319 @default.
• W3015116594 hasConcept C3013748606 @default.
• W3015116594 hasConcept C3019165603 @default.
• W3015116594 hasConcept C45189115 @default.
• W3015116594 hasConcept C71924100 @default.
• W3015116594 hasConceptScore W3015116594C126322002 @default.
• W3015116594 hasConceptScore W3015116594C142462285 @default.
• W3015116594 hasConceptScore W3015116594C159654299 @default.
• W3015116594 hasConceptScore W3015116594C16005928 @default.
• W3015116594 hasConceptScore W3015116594C167135981 @default.
• W3015116594 hasConceptScore W3015116594C187212893 @default.
• W3015116594 hasConceptScore W3015116594C195910791 @default.
• W3015116594 hasConceptScore W3015116594C203014093 @default.
• W3015116594 hasConceptScore W3015116594C2779437838 @default.
• W3015116594 hasConceptScore W3015116594C2993143319 @default.
• W3015116594 hasConceptScore W3015116594C3013748606 @default.
• W3015116594 hasConceptScore W3015116594C3019165603 @default.
• W3015116594 hasConceptScore W3015116594C45189115 @default.
• W3015116594 hasConceptScore W3015116594C71924100 @default.
• W3015116594 hasIssue "4" @default.
• W3015116594 hasLocation W30151165941 @default.
• W3015116594 hasOpenAccess W3015116594 @default.
• W3015116594 hasPrimaryLocation W30151165941 @default.
• W3015116594 hasRelatedWork W1985903363 @default.
• W3015116594 hasRelatedWork W1993670795 @default.
• W3015116594 hasRelatedWork W2032418787 @default.
• W3015116594 hasRelatedWork W2096794316 @default.
• W3015116594 hasRelatedWork W2113434257 @default.
• W3015116594 hasRelatedWork W2140289039 @default.
• W3015116594 hasRelatedWork W2142081045 @default.
• W3015116594 hasRelatedWork W2330170406 @default.
• W3015116594 hasRelatedWork W2349929775 @default.
• W3015116594 hasRelatedWork W2370955680 @default.
• W3015116594 hasRelatedWork W2374068988 @default.
• W3015116594 hasRelatedWork W2393623130 @default.
• W3015116594 hasRelatedWork W2412937715 @default.
• W3015116594 hasRelatedWork W3112044216 @default.
• W3015116594 hasRelatedWork W420894180 @default.
• W3015116594 hasRelatedWork W154608413 @default.
• W3015116594 hasRelatedWork W2185515361 @default.
• W3015116594 hasRelatedWork W2288467628 @default.
• W3015116594 hasRelatedWork W2289762561 @default.
• W3015116594 hasRelatedWork W2305563059 @default.
• W3015116594 hasVolume "30" @default.
• W3015116594 isParatext "false" @default.
• W3015116594 isRetracted "false" @default.
• W3015116594 magId "3015116594" @default.
• W3015116594 workType "article" @default.